Insider Trading Activity Celgene Corporation (NASDAQ:CELG) – Director Sold 7,500 shares of Stock

ME Staff
-
0

Insider Trading Activity For Celgene Corporation (NASDAQ:CELG)

Gilla Kaplan , Director of Celgene Corporation (NASDAQ:CELG) reportedly Sold 7,500 shares of the company’s stock at an average price of 134.52 for a total transaction amount of $1,008,900.00 SEC Form

Insider Trading History For Celgene Corporation (NASDAQ:CELG)

  • On 5/28/2013 Thomas O Daniel, Insider, sold 32,959 with an average share price of $124.91 per share and the total transaction amounting to $4,116,908.69.View SEC Filing
  • On 5/29/2013 Ernest Mario, Director, bought 1,000 with an average share price of $123.72 per share and the total transaction amounting to $123,720.00.View SEC Filing
  • On 5/30/2013 Robert J Hugin, Insider, sold 68,087 with an average share price of $123.58 per share and the total transaction amounting to $8,414,191.46.View SEC Filing
  • On 8/2/2013 Perry A Karsen, Insider, sold 93,008 with an average share price of $146.50 per share and the total transaction amounting to $13,625,672.00.View SEC Filing
  • On 8/28/2013 Thomas Daniel, Insider, sold 32,263 with an average share price of $137.06 per share and the total transaction amounting to $4,421,966.78.View SEC Filing
  • On 9/4/2013 Gilla Kaplan, Director, sold 15,000 with an average share price of $143.92 per share and the total transaction amounting to $2,158,800.00.View SEC Filing
  • On 10/25/2013 Carrie Smith Cox, Director, sold 18,750 with an average share price of $157.67 per share and the total transaction amounting to $2,956,312.50.View SEC Filing

    • Analyst Ratings For Celgene Corporation (NASDAQ:CELG)
    These are 1 Sell Rating, 4 Hold Ratings, 21 Buy Ratings .
    The current consensus rating for Celgene Corporation (NASDAQ:CELG) is Buy (Score: 2.77) with a consensus target price of $147.07 , a potential (8.22% upside)

    Analyst Ratings History For Celgene Corporation (NASDAQ:CELG)

    • On 12/18/2015 Atlantic Securities Initiated Coverage of rating Neutral to Neutral
    • On 1/22/2016 Wells Fargo & Company Reiterated Rating Outperform
    • On 4/28/2016 Raymond James Financial, Inc. Reiterated Rating Buy
    • On 7/6/2016 JMP Securities Reiterated Rating Buy with a price target of $152.00
    • On 9/29/2016 Citigroup Inc. Boost Price Target of rating Buy with a price target of $124.00 to $127.00
    • On 10/18/2016 Piper Jaffray Companies Reiterated Rating Buy
    • On 11/9/2016 Standpoint Research Downgraded rating Buy to Hold

    Recent Trading Activity for Celgene Corporation (NASDAQ:CELG)
    Shares of Celgene Corporation closed the previous trading session at 135.90 up +1.05 0.78% with 2,824,061 shares trading hands.